KROS · CIK 0001664710 · operating
Keros Therapeutics, Inc. (KROS) is a pharmaceutical preparations company, listed on the Nasdaq. With a market capitalization of $424 million, Keros Therapeutics, Inc. is a small-cap company. The stock currently trades at $13.91, down 1.97% today, with a 52-week range of $9.12–$22.55. The company trades at a trailing P/E of 9.1x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-5.00 | $-5.00 | +3.8% | |
| 2023 | $-5.20 | $-5.20 | -25.3% | |
| 2022 | $-4.15 | $-4.15 | -64.7% | |
| 2021 | $-2.52 | $-2.52 | — | |
| 2020 | — | — | — |